Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study
Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from its global Phase 3 efficacy
Read more